Abstract

Short chain fatty acids (SCFAs) are generated by the degradation and fermentation of complex carbohydrates, (i.e., dietary fiber) by the gut microbiota relevant for microbe–host communication. Here, we present a method for the quantification of SCFAs in fecal samples by liquid chromatography tandem mass spectrometry (LC-MS/MS) upon derivatization to 3-nitrophenylhydrazones (3NPH). The method includes acetate, propionate, butyrate, and isobutyrate with a run time of 4 min. The reproducible (coefficients of variation (CV) below 10%) quantification of SCFAs in human fecal samples was achieved by the application of stable isotope labelled internal standards. The specificity was demonstrated by the introduction of a quantifier and qualifier ions. The method was applied to investigate the pre-analytic stability of SCFAs in human feces. Concentrations of SCFA may change substantially within hours; the degree and kinetics of these changes revealed huge differences between the donors. The fecal SCFA level could be preserved by the addition of organic solvents like isopropanol. An analysis of the colon content of mice either treated with antibiotics or fed with a diet containing a non-degradable and -fermentable fiber source showed decreased SCFA concentrations. In summary, this fast and reproducible method for the quantification of SCFA in fecal samples provides a valuable tool for both basic research and large-scale studies.

Highlights

  • IntroductionSCFAs reach circulation via the portal vein and can alter the host metabolism and physiology substantially

  • Short-chain fatty acids (SCFAs) acetate (FA 2:0; annotation according to [1]), propionate (FA 3:0), and butyrate (FA 4:0) are generated as end products, by the degradation and fermentation of indigestible carbohydrates by the gut microbiota, a process termed saccharolytic fermentation [2].SCFAs reach circulation via the portal vein and can alter the host metabolism and physiology substantially

  • The SCFAs were determined in an aliquot representing 100 μg dry weight (DW)

Read more

Summary

Introduction

SCFAs reach circulation via the portal vein and can alter the host metabolism and physiology substantially. SCFA production was linked to preventing the progression of obesity and related complications, such as type 2 diabetes mellitus and nonalcoholic fatty liver disease (NAFLD) [3,4]. Related to these functions, we have just recently identified in mice that gut microbiota-derived acetate is an important precursor for the synthesis of fatty acids and phospholipids in the liver [5]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call